Skip to content

National Bank Alzheimer

National Bank Alzheimer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03687112
Acronym
BNA
Enrollment
167191
Registered
2018-09-27
Start date
2010-01-01
Completion date
2016-12-31
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease

Brief summary

The Alzheimer's disease (MY) is a major problem of public health. The French National Database Alzheimer ( BNA) registers(records) all the medical acts made by units of memory(report) and of independent specialists in France. In 2008, the national Plan Alzheimer 2008 - 2012 had for objective to strengthen the search(research) on the Alzheimer's disease (MY) and for related disorders(confusions), to promote an early diagnosis and to improve at the same time the management of the patients and to support careers(quarries). A specific part(party) of this plan gave rise to the creation of the French national database Alzheimer ( BNA) to supply epidemiological data as well as indicators of activity. Since 2009 The information collected(taken in) in the BNA consists of a set(group) limited by data (CIMA of information minimum Corpus Alzheimer) concerning the demographic, clinical and diagnostic data defined by national consensus. The number of variables is limited to facilitate and to improve the participation in this national database. The participants are the Centers Report (CM)((LECTURE)) and Center Memory(Report) of Resources and Search(Research) (CMRR) and independent specialists. In 2015 more than 500 Centers send CIMA to the BNA. The plan Disease Neurodegenerative 2014 - 2019 wishes to pursue and to amplify the BNA.

Interventions

OTHERnon ontervention / observational study

non intervention

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients consulting in French Memory Centres

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Evolution of the morbi-mortality16 yearsnumber of people suffering from a disease

Secondary

MeasureTime frameDescription
number of the miscellaneous determiners of Access to healthcare or diagnosis16 yearsnumber of the determiners of the access to healthcare and diagnosis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026